» Articles » PMID: 28646217

Why Do Physicians Lack Engagement with Smoking Cessation Treatment in Their COPD Patients? A Multinational Qualitative Study

Overview
Date 2017 Jun 25
PMID 28646217
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic Lung Disease: CHANGING ATTITUDES TO HELP PATIENTS STOP SMOKING: Doctors should be given careful, ethically-informed guidance during medical training to help them to support patients to quit smoking. The most important part of treatment for patients with chronic obstructive pulmonary disease (COPD) is help to stop smoking. However, there is evidence to suggest that doctors don't always motivate COPD patients to quit. Eva Anne Marije van Eerd at Maastrict University, The Netherlands, together with an international team of scientists, conducted focus group interviews with doctors in seven different countries to assess barriers to smoking cessation. They found that doctors' frustration with and negative attitudes towards patients who continued to smoke contributed to poor cessation management and treatment inequalities in some cases. Many doctors also cited a lack of experience with smoking cessation techniques alongside time and money issues as barriers to effective treatment.

Citing Articles

A service evaluation following the implementation of computer guided consultation software to support primary care reviews for chronic obstructive pulmonary disease.

Chakrabarti B, McKnight E, Pearson M, Dowie L, Richards J, Choudhury-Iqbal M NPJ Prim Care Respir Med. 2025; 35(1):12.

PMID: 40069195 PMC: 11897336. DOI: 10.1038/s41533-025-00421-1.


Smoking cessation program preferences of individuals with chronic obstructive pulmonary disease: a qualitative study.

Tregobov N, Starnes K, Kassay S, Mahjoob M, Chae Y, McMillan A Prim Health Care Res Dev. 2024; 25:e38.

PMID: 39301597 PMC: 11464802. DOI: 10.1017/S1463423624000306.


Effectiveness of immediate appointment scheduling in smoking cessation clinics for patients with chronic airway diseases: Preliminary results from a randomized trial.

Karadogan D, Telatar T, Kaya I, Atli S, Kose Kabil N, Marim F Tob Induc Dis. 2024; 22.

PMID: 39184066 PMC: 11342682. DOI: 10.18332/tid/191782.


Education for Tobacco Use Disorder Treatment: Current State, Evidence, and Unmet Needs.

Melzer A, Reese Z, Mascarhenas L, Clancy C, Deepak J, Gogineni H ATS Sch. 2024; 4(4):546-566.

PMID: 38196686 PMC: 10773493. DOI: 10.34197/ats-scholar.2022-0131RE.


Perceptions of the effectiveness of non-pharmacological management of respiratory disorders among CRD patients.

Aldabayan Y Medicine (Baltimore). 2023; 102(41):e35474.

PMID: 37832130 PMC: 10578682. DOI: 10.1097/MD.0000000000035474.


References
1.
George J, Kong D, Thoman R, Stewart K . Factors associated with medication nonadherence in patients with COPD. Chest. 2005; 128(5):3198-204. DOI: 10.1378/chest.128.5.3198. View

2.
van Eerd E, Risor M, van Rossem C, van Schayck O, Kotz D . Experiences of tobacco smoking and quitting in smokers with and without chronic obstructive pulmonary disease-a qualitative analysis. BMC Fam Pract. 2015; 16:164. PMC: 4634152. DOI: 10.1186/s12875-015-0382-y. View

3.
Danielsen S, Lochen M, Medbo A, Vold M, Melbye H . A new diagnosis of asthma or COPD is linked to smoking cessation - the Tromsø study. Int J Chron Obstruct Pulmon Dis. 2016; 11:1453-8. PMC: 4934533. DOI: 10.2147/COPD.S108046. View

4.
Tonnesen P, Mikkelsen K, Bremann L . Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. Chest. 2006; 130(2):334-42. DOI: 10.1378/chest.130.2.334. View

5.
Cahill K, Stevens S, Perera R, Lancaster T . Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013; (5):CD009329. PMC: 8406789. DOI: 10.1002/14651858.CD009329.pub2. View